CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1
Author:
Affiliation:
1. Department of Urology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
2. Department of Nuclear Medicine, Rostock University Medical Centre (SMS, BJK), Rostock, Germany
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference30 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015
2. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines;Witjes;Eur Urol,2014
3. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005
4. Comprehensive molecular characterization of urothelial bladder carcinoma;Nature,2014
5. The hallmarks of cancer;Hanahan;Cell,2000
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma;Journal for ImmunoTherapy of Cancer;2024-07
2. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo;Molecular Biology Reports;2024-03-27
3. p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer;Anticancer Research;2024-02
4. CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan;Cell Cycle;2023-06-02
5. Genome-Wide CRISPR Screening for the Identification of Therapy Resistance-Associated Genes in Urothelial Carcinoma;Urothelial Carcinoma;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3